Hi Sepfit, no idea unfortunately. I see the patent as a bonus here, as the success, or not, of the hospital trial and subsequent adoption of the AR applications will not hinge on the patent being granted. Clearly, however, the business needs to protect its IP and would be wanting the patent to be granted quickly. Others may well have a better, more informed idea.
General Company Chat, page-38
-
- There are more pages in this discussion • 2,411 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add VR1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.65M | |||
| Open | High | Low | Value | Volume |
| 2.1¢ | 2.1¢ | 2.1¢ | $1.753K | 83.49K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 384876 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 1229473 | 9 |
View Market Depth
| Last trade - 10.40am 26/07/2024 (20 minute delay) ? |
| VR1 (ASX) Chart |